Appealing to the top
Biotech tries to get its message to Clinton

WASHINGTON - Despite the recent high-visibility campaign against drug companies, President Bill Clinton and his aides understand that the U.S. biotechnology industry is a world leader that creates high-quality jobs and is not guilty of sins that Congress and the administration are attributing to the pharmaceutical industry, according to investment banker Sanford Robertson and Genentech chief executive G. Kirk Raab.

Robertson and Raab have moved to the center of an effort to resurrect the industry's fortunes, which have been turned upside down over a period of a few weeks. In interviews with BioCentury, they discussed how they are moving to stem the damage.